尼古丁替代疗法市场 - 全球产业规模、份额、趋势、机会与预测，按产品、配销通路、地区和竞争细分，2020-2030 年

2024 年全球尼古丁替代疗法市场价值为 538 亿美元，预计在预测期内将实现强劲增长，到 2030 年的复合年增长率为 8.20%。全球尼古丁替代疗法 (NRT) 市场是戒烟产品和服务领域中一个充满活力且不断发展的产业。它在帮助人们戒烟和克服尼古丁成瘾方面发挥关键作用。 NRT 市场涵盖一系列旨在帮助个人戒烟或使用烟草製品的产品和疗法。这些产品提供控制剂量的尼古丁，但不含香烟中的有害毒素，以减轻戒断症状和烟瘾。 NRT 产品有多种形式，包括尼古丁口香糖、贴片、含片、吸入器、鼻腔喷雾剂和处方药。

主要市场驱动因素

健康意识的提高和吸烟的有害影响

主要市场挑战

监管障碍和严格审批

主要市场趋势

电子商务和远距医疗服务的采用日益增多

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：尼古丁替代疗法市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（尼古丁替代疗法（吸入器、口香糖、透皮贴片、舌下片、含片等）、电子烟、加热不燃烧烟草产品）
  • 按配销通路（线下、线上）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美尼古丁替代疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲尼古丁替代疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区尼古丁替代疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲尼古丁替代疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲尼古丁替代疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 13 章：全球尼古丁替代疗法市场：SWOT 分析

第 14 章：竞争格局

• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Philip Morris Products SA
• British American Tobacco plc
• Japan Tobacco, Inc.
• Imperial Brands PLC
• Glenmark Ltd

第 15 章：策略建议

第16章调查会社について・免责事项

Global Nicotine Replacement Therapy Market was valued at USD 53.80 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.20% through 2030. The Global Nicotine Replacement Therapy (NRT) Market is a dynamic and evolving sector within the broader landscape of smoking cessation products and services. It plays a pivotal role in helping individuals quit smoking and overcome nicotine addiction. The NRT market encompasses a range of products and therapies designed to assist individuals in quitting smoking or using tobacco products. These products deliver controlled doses of nicotine, without the harmful toxins found in cigarettes, to reduce withdrawal symptoms and cravings. NRT products are available in various forms, including nicotine gum, patches, lozenges, inhalers, nasal sprays, and prescription medications.

Key Market Drivers

Rising Health Awareness and the Harmful Effects of Smoking

The increasing awareness of the health risks associated with smoking is a primary driver of the Global Nicotine Replacement Therapy (NRT) Market. As consumers become more informed about the dangers of tobacco use, demand for effective smoking cessation solutions continues to rise. This shift in consumer behavior, coupled with public health initiatives and regulatory support, is creating a strong market environment for NRT products such as nicotine patches, gums, lozenges, inhalers, and nasal sprays. According to the American Heart Association (AHA), smoking-related diseases are responsible for over 440,000 deaths annually in the United States. A significant concern is that the majority of new smokers are children and adolescents, highlighting a critical public health challenge. Smoking significantly elevates the risk of severe health conditions, including lung diseases such as lung cancer and emphysema, as well as cardiovascular diseases like heart disease and stroke. Public health campaigns, scientific studies, and widespread media coverage have significantly increased consumer awareness of the adverse effects of smoking. Tobacco use has been linked to a range of serious health conditions, including Smoking contributes to high blood pressure, heart attacks, and strokes. Smoking is a major contributor to cardiovascular disease, accounting for 20% of all smoking-related deaths. The risks are even more pronounced for women over 35 who smoke while taking oral contraceptives, as they face a significantly higher likelihood of heart disease, stroke, and blood clots. Additionally, cigarette smokers are 2 to 4 times more likely to develop heart disease compared to nonsmokers, creating a substantial burden on healthcare systems and workplace productivity.

Key Market Challenges

Regulatory Hurdles and Stringent Approvals

One of the primary challenges facing the NRT market is the lack of uniform regulations governing the sale and distribution of NRT products worldwide. Each country has its own regulatory framework, which can create complications for manufacturers trying to expand globally. Variances in regulations can lead to delays in product approvals and market entry.

NRT products often require rigorous clinical trials and safety assessments for regulatory approval. These processes can be time-consuming and costly. Delays in approvals can hinder the introduction of new and innovative NRT products, slowing market growth. The tobacco industry is a powerful entity with significant influence in some regions. It may lobby against NRT products as they can potentially reduce smoking rates. This lobbying can result in stricter regulations or negative public perceptions of NRT, hindering market growth.

In some cases, NRT products are erroneously categorized as tobacco products, subjecting them to tobacco-related regulations and taxes. This misclassification can increase costs for both manufacturers and consumers, making NRT less accessible.

Key Market Trends

Increasing Adoption of E-Commerce and Telehealth Services

The rise of e-commerce and telehealth services has transformed the way consumers access NRT products and smoking cessation support. E-commerce platforms provide a convenient and discreet way for individuals to purchase NRT products without visiting physical stores. Telehealth services offer remote consultations with healthcare professionals who can prescribe NRT products and provide personalized guidance for quitting smoking.

This trend has significantly expanded the reach of NRT products, making them more accessible to a broader audience. It has also enhanced user convenience, particularly during the COVID-19 pandemic when in-person visits to healthcare facilities were limited. As telehealth becomes more mainstream, it is likely to drive continued growth in the NRT market.

Key Market Players

• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Philip Morris Products S.A
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands PLC
• Glenmark Ltd

Report Scope:

In this report, the Global Nicotine Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotine Replacement Therapy Market, By Product:

• Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others)
• E-cigarettes
• Heat-not-burn Tobacco Products

Nicotine Replacement Therapy Market, By Distribution Channel:

• Offline
• Online

Nicotine Replacement Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotine Replacement Therapy Market.

Available Customizations:

Global Nicotine Replacement Therapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Nicotine Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others), E-cigarettes, Heat-not-burn Tobacco Products)
  • 5.2.2. By Distribution Channel (Offline, Online)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Nicotine Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nicotine Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Canada Nicotine Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Mexico Nicotine Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Distribution Channel

7. Europe Nicotine Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nicotine Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. United Kingdom Nicotine Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. Italy Nicotine Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. France Nicotine Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Nicotine Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Nicotine Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Nicotine Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. India Nicotine Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. Japan Nicotine Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. South Korea Nicotine Replacement Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. Australia Nicotine Replacement Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Distribution Channel

9. South America Nicotine Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Nicotine Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. Argentina Nicotine Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. Colombia Nicotine Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Nicotine Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Distribution Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Nicotine Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Saudi Arabia Nicotine Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. UAE Nicotine Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Nicotine Replacement Therapy Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Cipla Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Pfizer Inc.
• 14.3. Johnson & Johnson Services, Inc.
• 14.4. Philip Morris Products S.A
• 14.5. British American Tobacco p.l.c.
• 14.6. Japan Tobacco, Inc.
• 14.7. Imperial Brands PLC
• 14.8. Glenmark Ltd

15. Strategic Recommendations

16. About Us & Disclaimer